APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bicalutamide Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bicalutamide Tablets Industry Growth and Trends Forecast to 2032

22 December 202591 pages

Choose your research edition.

Industry ResearchBicalutamide Tablets Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Bicalutamide Tablets Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Bicalutamide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bicalutamide Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Bicalutamide Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Bicalutamide Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bicalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bicalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bicalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bicalutamide Tablets include HISUN, Fosun Pharma, FORWARD, AstraZeneca and CordenPharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bicalutamide Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bicalutamide Tablets market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bicalutamide Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bicalutamide Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bicalutamide Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bicalutamide Tablets Market by Company

HISUN

Fosun Pharma

FORWARD

AstraZeneca

CordenPharma

Bicalutamide Tablets Segment by Type

14 Tablets Per Box

28 Tablets Per Box

Bicalutamide Tablets Segment by Application

Hospital

Clinic

Bicalutamide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bicalutamide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bicalutamide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bicalutamide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bicalutamide Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bicalutamide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 14 Tablets Per Box Table 2. Major Company of 28 Tablets Per Box Table 3. Global Bicalutamide Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Bicalutamide Tablets Sales by Type (2021-2026) & (k units) Table 5. Global Bicalutamide Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Bicalutamide Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Bicalutamide Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Bicalutamide Tablets Price by Type (2021-2026) & (US$/unit) Table 9. Global Bicalutamide Tablets Sales by Type (2027-2032) & (k units) Table 10. Global Bicalutamide Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Bicalutamide Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Bicalutamide Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Bicalutamide Tablets Price by Type (2027-2032) & (US$/unit) Table 14. North America Bicalutamide Tablets Sales by Type (2021-2026) & (k units) Table 15. North America Bicalutamide Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Bicalutamide Tablets Sales by Type (2021-2026) & (k units) Table 17. Europe Bicalutamide Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Bicalutamide Tablets Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Bicalutamide Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Bicalutamide Tablets Sales by Type (2021-2026) & (k units) Table 21. Latin America Bicalutamide Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Bicalutamide Tablets Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Bicalutamide Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Bicalutamide Tablets Industry Trends Table 25. Bicalutamide Tablets Industry Drivers Table 26. Bicalutamide Tablets Industry Opportunities and Challenges Table 27. Bicalutamide Tablets Industry Restraints Table 28. Global Bicalutamide Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Bicalutamide Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Bicalutamide Tablets Sales by Company (2021-2026) & (k units) Table 31. Global Bicalutamide Tablets Sales Share by Company (2021-2026) Table 32. Global Bicalutamide Tablets Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Bicalutamide Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Bicalutamide Tablets Major Company Production Sites and Headquarters Table 35. Global Bicalutamide Tablets Company, Product Type & Application Table 36. Global Bicalutamide Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Bicalutamide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Bicalutamide Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Bicalutamide Tablets Sales by Region (2021-2026) & (k units) Table 41. Global Bicalutamide Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Bicalutamide Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Bicalutamide Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Bicalutamide Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Bicalutamide Tablets Sales by Region (2027-2032) & (k units) Table 46. Global Bicalutamide Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Bicalutamide Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Bicalutamide Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Bicalutamide Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Bicalutamide Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Bicalutamide Tablets Sales by Application (2021-2026) & (k units) Table 52. Global Bicalutamide Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Bicalutamide Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Bicalutamide Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Bicalutamide Tablets Price by Application (2021-2026) & (US$/unit) Table 56. Global Bicalutamide Tablets Sales by Application (2027-2032) & (k units) Table 57. Global Bicalutamide Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Bicalutamide Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Bicalutamide Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Bicalutamide Tablets Price by Application (2027-2032) & (US$/unit) Table 61. North America Bicalutamide Tablets Sales by Application (2021-2026) & (k units) Table 62. North America Bicalutamide Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Bicalutamide Tablets Sales by Application (2021-2026) & (k units) Table 64. Europe Bicalutamide Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Bicalutamide Tablets Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Bicalutamide Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Bicalutamide Tablets Sales by Application (2021-2026) & (k units) Table 68. Latin America Bicalutamide Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Bicalutamide Tablets Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Bicalutamide Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. HISUN Company Information Table 72. HISUN Business Overview Table 73. HISUN Bicalutamide Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. HISUN Bicalutamide Tablets Product Portfolio Table 75. HISUN Recent Development Table 76. Fosun Pharma Company Information Table 77. Fosun Pharma Business Overview Table 78. Fosun Pharma Bicalutamide Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Fosun Pharma Bicalutamide Tablets Product Portfolio Table 80. Fosun Pharma Recent Development Table 81. FORWARD Company Information Table 82. FORWARD Business Overview Table 83. FORWARD Bicalutamide Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. FORWARD Bicalutamide Tablets Product Portfolio Table 85. FORWARD Recent Development Table 86. AstraZeneca Company Information Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Bicalutamide Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. AstraZeneca Bicalutamide Tablets Product Portfolio Table 90. AstraZeneca Recent Development Table 91. CordenPharma Company Information Table 92. CordenPharma Business Overview Table 93. CordenPharma Bicalutamide Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. CordenPharma Bicalutamide Tablets Product Portfolio Table 95. CordenPharma Recent Development Table 96. North America Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. North America Bicalutamide Tablets Sales by Country (2021-2026) & (k units) Table 98. North America Bicalutamide Tablets Sales Market Share by Country (2021-2026) Table 99. North America Bicalutamide Tablets Sales Forecast by Country (2027-2032) & (k units) Table 100. North America Bicalutamide Tablets Sales Market Share Forecast by Country (2027-2032) Table 101. North America Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Bicalutamide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Bicalutamide Tablets Market Share by Country (2021-2026) Table 104. North America Bicalutamide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Bicalutamide Tablets Market Share Forecast by Country (2027-2032) Table 106. Europe Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Europe Bicalutamide Tablets Sales by Country (2021-2026) & (k units) Table 108. Europe Bicalutamide Tablets Sales Market Share by Country (2021-2026) Table 109. Europe Bicalutamide Tablets Sales Forecast by Country (2027-2032) & (k units) Table 110. Europe Bicalutamide Tablets Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Bicalutamide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Bicalutamide Tablets Market Share by Country (2021-2026) Table 114. Europe Bicalutamide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Bicalutamide Tablets Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Bicalutamide Tablets Sales by Country (2021-2026) & (k units) Table 118. Asia-Pacific Bicalutamide Tablets Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Bicalutamide Tablets Sales Forecast by Country (2027-2032) & (k units) Table 120. Asia-Pacific Bicalutamide Tablets Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Bicalutamide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Bicalutamide Tablets Market Share by Country (2021-2026) Table 124. Asia-Pacific Bicalutamide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Bicalutamide Tablets Market Share Forecast by Country (2027-2032) Table 126. Latin America Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Latin America Bicalutamide Tablets Sales by Country (2021-2026) & (k units) Table 128. Latin America Bicalutamide Tablets Sales Market Share by Country (2021-2026) Table 129. Latin America Bicalutamide Tablets Sales Forecast by Country (2027-2032) & (k units) Table 130. Latin America Bicalutamide Tablets Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Bicalutamide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Bicalutamide Tablets Market Share by Country (2021-2026) Table 134. Latin America Bicalutamide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Bicalutamide Tablets Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Bicalutamide Tablets Sales by Country (2021-2026) & (k units) Table 138. Middle East and Africa Bicalutamide Tablets Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Bicalutamide Tablets Sales Forecast by Country (2027-2032) & (k units) Table 140. Middle East and Africa Bicalutamide Tablets Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Bicalutamide Tablets Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Bicalutamide Tablets Market Share by Country (2021-2026) Table 144. Middle East and Africa Bicalutamide Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Bicalutamide Tablets Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Bicalutamide Tablets Distributors List Table 149. Bicalutamide Tablets Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Bicalutamide Tablets Image Figure 2. Global Bicalutamide Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bicalutamide Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Bicalutamide Tablets Sales (2021-2032) & (k units) Figure 5. 14 Tablets Per Box Image Figure 6. Global 14 Tablets Per Box Sales YoY Growth (2021-2032) & (k units) Figure 7. 28 Tablets Per Box Image Figure 8. Global 28 Tablets Per Box Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Bicalutamide Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Bicalutamide Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Bicalutamide Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Bicalutamide Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Bicalutamide Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Bicalutamide Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Bicalutamide Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Bicalutamide Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Bicalutamide Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Bicalutamide Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Bicalutamide Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Bicalutamide Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Bicalutamide Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Bicalutamide Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Bicalutamide Tablets Market Share by Application 2025 VS 2032 Figure 29. North America Bicalutamide Tablets Sales Market Share in Volume by Application in 2025 Figure 30. North America Bicalutamide Tablets Sales Market Share in Value by Application in 2025 Figure 31. Europe Bicalutamide Tablets Sales Market Share in Volume by Application in 2025 Figure 32. Europe Bicalutamide Tablets Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Bicalutamide Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Bicalutamide Tablets Sales Market Share in Value by Application in 2025 Figure 35. Latin America Bicalutamide Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Bicalutamide Tablets Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Bicalutamide Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Bicalutamide Tablets Sales Market Share in Value by Application in 2025 Figure 39. North America Bicalutamide Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Bicalutamide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Bicalutamide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Bicalutamide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Bicalutamide Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Bicalutamide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Bicalutamide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Bicalutamide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Bicalutamide Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Bicalutamide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Bicalutamide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Bicalutamide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Bicalutamide Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Bicalutamide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Bicalutamide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Bicalutamide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Bicalutamide Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Bicalutamide Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Bicalutamide Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Bicalutamide Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Bicalutamide Tablets Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Bicalutamide Tablets Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 14 Tablets Per Box
  • 28 Tablets Per Box
Applications
  • Hospital
  • Clinic
Companies covered
  • HISUN
  • Fosun Pharma
  • FORWARD
  • AstraZeneca
  • CordenPharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bicalutamide Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bicalutamide Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bicalutamide Tablets Market by Type
  6. 1.3.1 14 Tablets Per Box
  7. 1.3.2 28 Tablets Per Box
  8. 1.4 Global Bicalutamide Tablets Market Size by Type
  9. 1.4.1 Global Bicalutamide Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Bicalutamide Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Bicalutamide Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Bicalutamide Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Bicalutamide Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Bicalutamide Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Bicalutamide Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Bicalutamide Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bicalutamide Tablets Industry Trends
  2. 2.2 Bicalutamide Tablets Industry Drivers
  3. 2.3 Bicalutamide Tablets Industry Opportunities and Challenges
  4. 2.4 Bicalutamide Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bicalutamide Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Bicalutamide Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Bicalutamide Tablets Price (2021-2026)
  4. 3.4 Global Bicalutamide Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bicalutamide Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Bicalutamide Tablets Company, Product Type & Application
  7. 3.7 Global Bicalutamide Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bicalutamide Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bicalutamide Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bicalutamide Tablets Tier 1, Tier 2, and Tier 3
4 Bicalutamide Tablets Regional Status and Outlook
  1. 4.1 Global Bicalutamide Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bicalutamide Tablets Historic Market Size by Region
  3. 4.2.1 Global Bicalutamide Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bicalutamide Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bicalutamide Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bicalutamide Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Bicalutamide Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bicalutamide Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bicalutamide Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bicalutamide Tablets by Application
  1. 5.1 Bicalutamide Tablets Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Bicalutamide Tablets Market Size by Application
  5. 5.2.1 Global Bicalutamide Tablets Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Bicalutamide Tablets Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Bicalutamide Tablets Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Bicalutamide Tablets Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Bicalutamide Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Bicalutamide Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Bicalutamide Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Bicalutamide Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 HISUN
  2. 6.1.1 HISUN Company Information
  3. 6.1.2 HISUN Business Overview
  4. 6.1.3 HISUN Bicalutamide Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 HISUN Bicalutamide Tablets Product Portfolio
  6. 6.1.5 HISUN Recent Developments
  7. 6.2 Fosun Pharma
  8. 6.2.1 Fosun Pharma Company Information
  9. 6.2.2 Fosun Pharma Business Overview
  10. 6.2.3 Fosun Pharma Bicalutamide Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Fosun Pharma Bicalutamide Tablets Product Portfolio
  12. 6.2.5 Fosun Pharma Recent Developments
  13. 6.3 FORWARD
  14. 6.3.1 FORWARD Company Information
  15. 6.3.2 FORWARD Business Overview
  16. 6.3.3 FORWARD Bicalutamide Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 FORWARD Bicalutamide Tablets Product Portfolio
  18. 6.3.5 FORWARD Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Bicalutamide Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Bicalutamide Tablets Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 CordenPharma
  26. 6.5.1 CordenPharma Company Information
  27. 6.5.2 CordenPharma Business Overview
  28. 6.5.3 CordenPharma Bicalutamide Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CordenPharma Bicalutamide Tablets Product Portfolio
  30. 6.5.5 CordenPharma Recent Developments
7 North America by Country
  1. 7.1 North America Bicalutamide Tablets Sales by Country
  2. 7.1.1 North America Bicalutamide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bicalutamide Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Bicalutamide Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bicalutamide Tablets Market Size by Country
  6. 7.2.1 North America Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bicalutamide Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Bicalutamide Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bicalutamide Tablets Sales by Country
  2. 8.1.1 Europe Bicalutamide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bicalutamide Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Bicalutamide Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bicalutamide Tablets Market Size by Country
  6. 8.2.1 Europe Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bicalutamide Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bicalutamide Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bicalutamide Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Bicalutamide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bicalutamide Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bicalutamide Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bicalutamide Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bicalutamide Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bicalutamide Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bicalutamide Tablets Sales by Country
  2. 10.1.1 South America Bicalutamide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bicalutamide Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Bicalutamide Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bicalutamide Tablets Market Size by Country
  6. 10.2.1 South America Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bicalutamide Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Bicalutamide Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bicalutamide Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Bicalutamide Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bicalutamide Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bicalutamide Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bicalutamide Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Bicalutamide Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bicalutamide Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bicalutamide Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bicalutamide Tablets Value Chain Analysis
  2. 12.1.1 Bicalutamide Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bicalutamide Tablets Production Mode & Process
  7. 12.2 Bicalutamide Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bicalutamide Tablets Distributors
  10. 12.2.3 Bicalutamide Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst